Document Detail

Perspectives from the clinic: will the average physician embrace personalized medicine?
MedLine Citation:
PMID:  18253143     Owner:  NLM     Status:  MEDLINE    
In 1961, Richard Asher argued that the clinical question regarding a particular intervention is not "should it work?" but rather "does it work?". Since that time, clinical trials have become the cornerstone of clinical science, providing physicians access to an expanding pharmacopeia of therapeutic options. The new capacity to change the course of illness has transformed patients' lives as well as the clinical encounter. The recent call for personalized medicine is an attempt to further our therapeutic effectiveness.
H Levy; J H Young
Related Documents :
23283153 - Tracking of medicine use and self-medication from infancy to adolescence: 1993 pelotas ...
10868263 - The central equipment pool, an opportunity for improved technology management.
10491233 - Residency application statements can predict postresidency training.
Publication Detail:
Type:  Journal Article; Review     Date:  2008-02-06
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  83     ISSN:  1532-6535     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-02-20     Completed Date:  2008-03-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  492-3     Citation Subset:  AIM; IM    
Division of General Internal Medicine, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Attitude of Health Personnel*
Pharmacogenetics / trends*
Physician's Role*
Physician-Patient Relations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effect of globalization of drug manufacturing, production, and sourcing and challenges for Ameri...
Next Document:  Pharmacogenetics: from bench to byte.